HHS Plans Interim Sole-Source Claude Award Before Competitive AI BPA

The U.S. Department of Health and Human Services (HHS) plans to award Anthropic a limited, sole-source contract to continue providing its Claude services. The notice, posted on SAM.gov, identifies the procurement as 7571TE27R00001 and describes the action as a “limited continuity of services award.” HHS says the interim arrangement will bridge existing services while the department prepares to procure enterprise AI through a competitive, multiple-award blanket purchase agreement (BPA). The notice does not disclose the award value or a specific award date, and it does not establish when the planned competition will be active or when a solicitation may be released.

HHS’s stated rationale centers on maintaining an existing Claude deployment. The notice describes Claude as the only tool that can fulfill the department’s current needs, citing chat, drafting, summarization, data-analysis workflows, application access, and administrative controls. It says, “The capability is specific to one provider: Claude is Anthropic’s proprietary model family, and the requirement is continuity of the existing Claude deployment already.” That framing makes continuity—not a clearly detailed set of unique technical requirements—the central argument for the interim sole-source action. The future competitive BPA, if issued as described, could broaden access for other providers of enterprise AI models and related services.

HHS has used Claude across its workforce since December 2025, after Anthropic offered its services to agencies for $1 a year. The department’s 2025 AI inventory cited Claude use cases, and the Food and Drug Administration (FDA) used Claude in its Elsa chatbot. The source reports that the FDA began transitioning Elsa to Google’s Gemini earlier in 2026, following the Trump administration’s governmentwide ban on Anthropic after the company’s dispute with the Pentagon. The related legal battle remains ongoing. Separately, Anthropic’s discounted agency offer through the General Services Administration’s OneGov initiative is scheduled to end October 31; the source notes that this end date follows an extension of the original deal.

The notice has prompted scrutiny of HHS’s reliance on a single provider and of whether the stated capabilities support a sole-source approach. Jessica Tillipman, associate dean for Government Procurement Law Studies at George Washington University, said the notice appears to acknowledge agency dependence on Claude and questioned whether general chatbot functions justify limiting competition. She warned that difficulty or cost in switching vendors could indicate poor planning, a concern commonly described as vendor lock-in. For contractors, the planned BPA is the principal forward-looking opportunity: companies should map their offerings to HHS’s listed functions, prepare evidence of interoperability and migration support, and monitor SAM.gov for a solicitation and acquisition schedule. The source provides no confirmed timeline, so firms should treat the competition as planned rather than currently open.

• Procurement vehicle: HHS disclosed intent to make a limited sole-source continuity award under contract 7571TE27R00001.
• Interim vendor and service: Anthropic would continue providing Claude; the notice gives no award amount or specific award date.
• Stated capability areas: Chat, drafting, summarization, data-analysis workflows, application access, and administrative controls.
• Future competition: HHS is preparing a competitive, multiple-award BPA for enterprise AI services; no solicitation or award timeline is provided.
• Existing use: HHS rolled out Claude to its workforce in December 2025 and cited use cases in its 2025 AI inventory.
• FDA transition: The source says FDA began moving its Elsa chatbot from Claude to Google’s Gemini earlier in 2026.
• Pricing context: Anthropic’s agency offer was $1 a year; its discounted OneGov deal is set to end October 31, following an extension.
• Market and policy context: The source describes an ongoing legal dispute following a governmentwide ban on Anthropic tied to its clash with the Pentagon.
• Contractor actions: Enterprise AI vendors should document how their products meet the listed functions and demonstrate secure integration, administrative controls, continuity, and migration options.
• Competition watch: Monitor SAM.gov for the planned BPA; the interim notice does not establish when the broader procurement will begin.